AtriCure price target raised to $60 from $50 at Piper Sandler
bullish
Public signal · 1-minute delayed
Source-backed market context you can read and share without an account.
bullish
What happened, with direct paths to the underlying reporting
Piper Sandler raises ATRC target to $60 from $50; current price $48.17; priceChangeSinceSignal +2.28.
Target: $60
Posted price: $48.17
Analyst firm: Piper Sandler
Analyst: Matt O'Brien
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.